Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy by Shin Hye Yoo, Seo Young Kang, Jeesun Yoon, Tae-Yong Kim, Gi Jeong Cheon, Do-Youn Oh

Get full text

631 Pharmacokinetics and pharmacodynamics study of TU2218, TGFβRI and VEGFR2 dual inhibitor in patients with advanced solid tumors by Do-Youn Oh, Anthony W Tolcher, Kyu Pyo Kim, Hyesung Shin, Huntaek Kim, Soo Jin Kim, Eunsun Lee

The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy by Hyunkyung Park, Ju‐Hee Bang, Ah‐Rong Nam, Ji Eun Park, Mei Hua Jin, Yung‐Jue Bang, Do‐Youn Oh

Get full text

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. by Younak Choi, Do-Youn Oh, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang

Get full text

More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity. by Younak Choi, Do-Youn Oh, Hyunkyung Park, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang

Get full text

Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck... by Yuichiro Doki, Makoto Ueno, Chih‐Hung Hsu, Do‐Youn Oh, Keunchil Park, Noboru Yamamoto, Tatsuya Ioka, Hiroki Hara, Manabu Hayama, Masahiro Nii, Keiko Komuro, Mariko Sugimoto, Makoto Tahara

Get full text

288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors by Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Do-Youn Oh, Jeeyun Lee, Won Ki Kang, Yeon Hee Park, Ji Hye Lee, Yun Jeong Song, Young Suk Park

A target‐mediated drug disposition population pharmacokinetic model of GC1118, a novel anti‐EGFR antibody, in patients with solid tumors by Tae Kyu Chung, Hyun A. Lee, Sang‐In Park, Do‐Youn Oh, Keun‐Wook Lee, Jin Won Kim, Jee Hyun Kim, Ahmi Woo, Su Jin Lee, Yung‐Jue Bang, Howard Lee

Get full text

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma by Dae-Won Lee, Kyung-Hun Lee, Hee-Jun Kim, Tae-Yong Kim, Jin-Soo Kim, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Seock-Ah Im, Tae-You Kim

Get full text

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy by Jin Won Kim, Ahrum Min, Seock-Ah Im, Hyemin Jang, Yu Jin Kim, Hee-Jun Kim, Kyung-Hun Lee, Tae-Yong Kim, Keun Wook Lee, Do-Youn Oh, Jee-Hyun Kim, Yung-Jue Bang

Get full text

Clinical insights on outcomes of corticosteroid administration in immune checkpoint inhibitor-induced pneumonitis by retrospective case series analysis by Changhee Park, Bhumsuk Keam, Soon Ho Yoon, Chan-Young Ock, Sun Mi Choi, Miso Kim, Young Sik Park, Tae Min Kim, Do-Youn Oh, Dong-Wan Kim, Young Whan Kim, Dae Seog Heo, Yung-Jue Bang

Get full text

617 A Phase I study of a tumor-targeted, fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors by Antoine Hollebecque, Victor Moreno, Do-Youn Oh, Ignacio Melero, James Spicer, Iben Spanggaard, Fiona C Thistlethwaite, Stefan Symeonides, Maria Lostes Baradji, Dae Lee, Corinne Rusterholz, Olivera Cirovic, Yvonne Zhao, Nicole Kratochwil, Bernhard Reis, Alexandra Epp, Georgios Kazantzidis

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer. by Hye Rim Ha, Do-Youn Oh, Tae-Yong Kim, KyoungBun Lee, Kyubo Kim, Kyung-Hun Lee, Sae-Won Han, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Yung-Jue Bang

Get full text

Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer by Antoine Hollebecque, Rocio Garcia-Carbonero, Do-Youn Oh, Emiliano Calvo, Davide Melisi, Teresa Macarulla, Valeria Merz, Erkut Borazanci, Anna Varghese, Camilla Zecchetto, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Shawn T Estrem, Karim A Benhadji, Emin Avsar, Susan C Guba

Get full text

Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group by Changhoon Yoo, Hyeon-Su Im, Kyu-pyo Kim, Do-Youn Oh, Kyung-Hun Lee, Hong Jae Chon, Joo Hoon Kim, Myoungjoo Kang, Ilhwan Kim, Guk Jin Lee, Sung Yong Oh, Younak Choi, Hye Jin Choi, Seung Tae Kim, Joon Oh Park, Baek-Yeol Ryoo

Get full text

Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody. by Jun Gyu Kim, Min Jueng Kang, Young-Kwang Yoon, Hwang-Phill Kim, Jinah Park, Sang-Hyun Song, Sae-Won Han, Jong-Wan Park, Gyeong Hoon Kang, Keon Wook Kang, Do Youn Oh, Seock-Ah Im, Yung-Jue Bang, Eugene C Yi, Tae-You Kim

Get full text

614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study by Bhumsuk Keam, Chan-Young Ock, Do-Youn Oh, Seung-Tae Kim, Keun-Wook Lee, Sun Young Rha, Changhoon Yoo, John Park, Min Hwan Kim, Sehyun Kim, Dhanusha Sabanathan, Joon Oh Park, Napa Parinyanitikul, Kyu Pyo Kim, Jaebong Yoon, Hyelim Lim, Sangheon Lee, Wooick Jang

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, rando... by Tanios Bekaii-Saab, Takuji Okusaka, David Goldstein, Do-Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric C. Anderson, Marcus S. Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung-Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem

Get full text

409 Trial in progress: a phase 2 study to assess the safety, efficacy of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancer by Do-Youn Oh, Jeeyun Lee, Keun-Wook Lee, Hyun Cheol Chung, Michael Chisamore, Paul Rhee, Taewan Kim, Sang Cheul Oh, Min Hee Ryu, Jun-Eul Hwang, Jaeyong Cho, Dae Young Zang, Byoung Yong Shim, William Ho, Ji Yeong Won, Eunhye Baek, SeungJae Baek

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma by Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado, Ignacio Duran, Do-Youn Oh, Stephen K. Williamson, Pablo Gajate, Hendrik-Tobias Arkenau, Robert J. Jones, Min Yuen Teo, Tolga Turan, Robert T. McLaughlin, Hillary M. Peltier, Elizabeth Chong, Harisha Atluri, James P. Dean, Daniel Castellano

Get full text